Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study" [Radiother. Oncol. 172 (2022) 111-117].
Price JM, West CM, Dixon LM, Iyizoba-Ebozue Z, Garcez K, Lee LW, McPartlin A, Williams G, Slevin F, Sykes A, Prestwich RJD, Thomson DJ. Price JM, et al. Among authors: prestwich rjd. Radiother Oncol. 2022 Dec;177:163. doi: 10.1016/j.radonc.2022.10.014. Epub 2022 Nov 14. Radiother Oncol. 2022. PMID: 36395551 No abstract available.
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.
Thomson DJ, Cruickshank C, Baines H, Banner R, Beasley M, Betts G, Bulbeck H, Charlwood F, Christian J, Clarke M, Donnelly O, Foran B, Gillies C, Griffin C, Homer JJ, Langendijk JA, Lee LW, Lester J, Lowe M, McPartlin A, Miles E, Nutting C, Palaniappan N, Prestwich R, Price JM, Roberts C, Roe J, Shanmugasundaram R, Simões R, Thompson A, West C, Wilson L, Wolstenholme J, Hall E. Thomson DJ, et al. Among authors: prestwich r. Clin Transl Radiat Oncol. 2022 Nov 21;38:147-154. doi: 10.1016/j.ctro.2022.11.010. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36452431 Free PMC article.
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma.
Errington F, White CL, Twigger KR, Rose A, Scott K, Steele L, Ilett LJ, Prestwich R, Pandha HS, Coffey M, Selby P, Vile R, Harrington KJ, Melcher AA. Errington F, et al. Among authors: prestwich r. Gene Ther. 2008 Sep;15(18):1257-70. doi: 10.1038/gt.2008.58. Epub 2008 Apr 10. Gene Ther. 2008. PMID: 18401435 Free PMC article.
Immunotherapeutic potential of oncolytic virotherapy.
Prestwich RJ, Harrington KJ, Vile RG, Melcher AA. Prestwich RJ, et al. Lancet Oncol. 2008 Jul;9(7):610-2. doi: 10.1016/S1470-2045(08)70163-3. Lancet Oncol. 2008. PMID: 18598928 No abstract available.
Cancer immunotherapy.
Prestwich R, Vile R, Melcher A. Prestwich R, et al. N Engl J Med. 2008 Sep 4;359(10):1072; author reply 1073. N Engl J Med. 2008. PMID: 18777615 No abstract available.
The importance of the immune system in reovirus therapy.
Prestwich RJ, Ilett EJ, Steele L, Errington F. Prestwich RJ, et al. Clin Oncol (R Coll Radiol). 2008 Dec;20(10):769. doi: 10.1016/j.clon.2008.08.004. Epub 2008 Sep 27. Clin Oncol (R Coll Radiol). 2008. PMID: 18824336 No abstract available.
121 results